Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.48
0.04 (0.54%)
At close: Aug 18, 2025, 3:02 PM

Bicycle Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-169.03M -180.66M -112.72M -66.82M
Depreciation & Amortization
7.17M 6.55M 3.69M 1.41M
Stock-Based Compensation
38.08M 32.48M 26.78M 12.08M
Other Working Capital
-24.61M 69.86M 9.46M 37.12M
Other Non-Cash Items
-2.26M 734.03K 442K 2.14M
Deferred Income Tax
-5.23M 3.32M -4.98M -1.67M
Change in Working Capital
-33.46M 76.96M 672K 38.06M
Operating Cash Flow
-164.72M -60.63M -86.11M -14.79M
Capital Expenditures
-1.24M -2.93M -18.99M -2.03M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-1.24M -2.93M -18.99M -2.03M
Debt Repayment
-31.91M n/a n/a 15M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.53M 682K 989K 7.18M
Financial Cash Flow
519.75M 250.03M 6.69M 320.73M
Net Cash Flow
353.1M 187.82M -99.53M 302.69M
Free Cash Flow
-165.96M -63.56M -105.1M -16.82M